<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Weatherall Inst of Molecular Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BB3C4D68-B138-474C-8AEA-C7880419D2C1"><gtr:id>BB3C4D68-B138-474C-8AEA-C7880419D2C1</gtr:id><gtr:firstName>Gil</gtr:firstName><gtr:surname>McVean</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E08F7CF9-201C-4200-ADB0-8467A9989AF4"><gtr:id>E08F7CF9-201C-4200-ADB0-8467A9989AF4</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Holmes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D6784BA3-960E-40CB-8663-A597913E4CF5"><gtr:id>D6784BA3-960E-40CB-8663-A597913E4CF5</gtr:id><gtr:firstName>D</gtr:firstName><gtr:surname>Higgs</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F45665EC-078B-49F1-8AEF-0F7A84769CF3"><gtr:id>F45665EC-078B-49F1-8AEF-0F7A84769CF3</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:surname>Brockdorff</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E152F8DC-B44A-4592-BCC4-42CF9258AD52"><gtr:id>E152F8DC-B44A-4592-BCC4-42CF9258AD52</gtr:id><gtr:firstName>Kay</gtr:firstName><gtr:surname>Davies</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8F8C28F1-22C4-4E4D-935B-A431D732F5B8"><gtr:id>8F8C28F1-22C4-4E4D-935B-A431D732F5B8</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Ponting</gtr:surname><gtr:orcidId>0000-0003-0202-7816</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C79EE0CB-A287-4F81-A094-E69B1EC1724A"><gtr:id>C79EE0CB-A287-4F81-A094-E69B1EC1724A</gtr:id><gtr:firstName>Adam</gtr:firstName><gtr:surname>Mead</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F1D1CEC4-C1D4-4B6C-9629-E4522EFDA6E2"><gtr:id>F1D1CEC4-C1D4-4B6C-9629-E4522EFDA6E2</gtr:id><gtr:firstName>Sten</gtr:firstName><gtr:otherNames>Eirik</gtr:otherNames><gtr:surname>Jacobsen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FM00919X%2F1"><gtr:id>84EC19D8-F29B-42D4-A1A3-9AC4C45BB7C2</gtr:id><gtr:title>The Oxford Single Cell Biology Consortium</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/M00919X/1</gtr:grantReference><gtr:abstractText>Limitations in our ability to study the biology of individual cells has historically been a major obstacle, inhibiting our understanding of some fundamental problems in biomedical research such as the onset of cancer, the immunological determination of 'self', and the ability to purify tissue-specific stem cells. Recent developments in the field of single cell genomics is now opening up unprecedented opportunities to uncover individual cell differences within such complex tissues. The objective of the proposed research is to establish a Centre of Single Cell Biology (CSCB) in Oxford that will take advantage of this pioneering technology in order to improve the diagnosis, stratification and treatment of a wide variety of human diseases. The CSCB will be coordinated by the Weatherall Institute of Molecular Medicine (WIMM) which has a long-standing technical and strategic expertise in single cell research. The capital development will be used to enhance single-cell research capabilities across the campus in a number of key areas:

Data analysis: Single cell genomics studies generate an enormous amount of data, with consequent challenges for the analysis and correct interpretation of these complex data sets. We propose to establish an entirely new research group devoted to the development of novel approaches for the statistical and computational analysis of single cell biology data and its application to medicine. This group will be located in new space to be developed at the WIMM, but jointly led by leading scientists across the campus. This new initiative will provide a clear pathway to integrate multidisciplinary, scientific and technical innovation in single cell biology research across the Oxford University Campus and to provide ground-breaking applications of this approach to medicine in the UK.

State of the art facilities: We will develop single cell biology research laboratories to allow practical access for research groups conducting these studies across the campus. These facilities will house cutting edge technology platforms and, importantly, will create &amp;quot;ultra clean&amp;quot; environments to carry out single cell experiments. This is necessary as very low levels of background &amp;quot;contamination&amp;quot; make the interpretation of single cell experiments challenging. 

Projects: As a specific example of how this technology will be applied to address fundamental problems in human disease, the lead programme of research in the CSCB will be focused on inherited disorders of red blood cells. These disorders are amongst the most common of all human genetic diseases worldwide with an estimated 300,000 affected babies born each year and a total number of affected UK patients of ~16,000. Currently, severely affected individuals are treated with supportive care, including lifelong blood transfusion and treatment to prevent accumulation of iron in the body, which is costly, burdensome, and gives rise to serious, long-term clinical complications. Here we propose to &amp;quot;genetically repair&amp;quot; the damaged genes in the patient's own blood stem cells. Single cell biology will be central to this project: First, single cell genomic approaches will be used to identify the blood stem cells which are the best target for this therapy. Second, single-cell analysis will be used to assess the safety and efficiency of this approach. This programme, focussed on developing an entirely new approach to treating the haemoglobinopathies, has the potential to transform the treatment of all human genetic diseases that can be cured by stem cell transplantation. This is one example of many projects in development across the campus which will be greatly facilitated by the development of improved single cell research capabilities.

Oxford is in a very strong position to take a world-leading role in the up-and-coming area of Single Cell Biology and application of these technologies to important clinical and basic biology questions across the University and beyond.</gtr:abstractText><gtr:technicalSummary>We will establish a Centre of Single Cell Biology in Oxford that will improve the diagnosis, stratification and treatment of a wide variety of human diseases. The Centre will be coordinated from the Weatherall Institute of Molecular Medicine (WIMM), which has established technical and strategic expertise in single cell research, and will share experimental and analytical best practice with two linked experimental sites, at the Wellcome Trust Centre for Human Genetics (WTCHG) and the MRC Functional Genomics Unit (FGU). The Centre's lead project will use a combination of single cell genomic analysis and functional assays at the clonal level to refine current stem/progenitor/effector cell purification strategies for transplantation with the ultimate aim of developing entirely new approaches to therapy in blood diseases. This single cell expertise and platforms in haematopoiesis will be used as a paradigm to develop parallel cutting-edge translational programmes for other inherited and acquired human diseases (such as in Immunology, Cancer Biology and Neurology). 

There are considerable computational and statistical challenges involved in state-of-the-art analysis and modelling of single cell data. To address these, the experimental single cell studies at the WIMM will interlink with the activities of the internationally renowned computational and statistical biologists from FGU and WTCHG. Specifically, we will establish an entirely new research group devoted to develop and apply novel approaches to the statistical and computational analysis of single cell biology and its application to medicine. This new initiative will provide a clear pathway to integrate multidisciplinary, scientific and technical innovation in single cell biology research across the Oxford University Campus and to provide ground-breaking applications of this approach to medicine in the UK.</gtr:technicalSummary><gtr:potentialImpactText>This research will have a clear beneficial impact well beyond the immediate professional circle carrying out similar research. For example:

Academic Impact: As outlined in the academic beneficiaries statement, there is clear potential for academic impact in a number of key areas, including, but not limited to, computational analysis of complex single cell data sets, development of new techniques for single cell analysis, application of genomic engineering techniques for therapeutic use, understanding of ageing, understanding cell fate decisions and refining diagnosis and stratification of disease.

Beneficiaries in the commercial private sector: We have established a strategic partnership with Fluidigm, the world leader in microfluidic devices for single cell analysis. This partnership will include access to novel technology platforms and a dynamic and mutually beneficial sharing of information. Fluidigm will also co-sponsor our planned single-cell annual data analysis workshop, again, with clear potential for mutual benefit. This partnership will help to secure further inward investment and gain access to cutting-edge technologies.

Contribution to the nation's health: Our overarching goal is to accelerate the recent advances in single cell technologies though to patient benefit. There are a number of key areas where this might be achieved. First, improved understanding of complex tissues, for example, through refined stem cell purification strategies has clear potential to improve outcome of stem cell transplantation procedures, which are still associated with considerable morbidity and mortality. Second, the application of single cell genomic approaches to help accelerate the development of techniques to &amp;quot;genetically repair&amp;quot; inherited disorders of blood cells has clear potential to transform the application of single cell genomics into a major clinical research activity, with broad cross-disciplinary applicability. The concept of correcting inherited genetic abnormalities clearly has far reaching potential to contribute to improvement in the nation's health. Third, single cell genomics approaches will help to further develop and refine diagnostic and stratification approaches in human disease and thereby personalize patient management, for example though a deeper understanding of clonal complexity of tumour propagating cancer stem cells, and monitoring of these cells throughout the disease course and impact of therapy. Finally, single cell analysis offers the potential to provide unique insights into the ageing process at the single (stem) cell level, and how this affects tissue function and contributes to age-dependent disease (tissue degeneration, cancer).

Dissemination of knowledge: As outlined in the communication plan, the lead investigators have considerable experience of disseminating scientific research findings across academic peers and more broadly with the public, including schools, and also for inspiring young potential scientists. A number of specific initiatives will be developed to help disseminate research conducted by the Centre of Single Cell Biology, including a new website and an annual single cell workshop.

New processes: Techniques in single cell technology are likely to develop rapidly over the coming years. If funded, the Oxford Centre of Single Cell Biology will place the MRC at the forefront of these developments. As an example, the WIMM introduced the first Fluidigm C1 microfluidics platform in Europe in 2012. This new technology allows capture of single primary cells and the interrogation of RNA and DNA content by multiplex PCR or through whole transcriptome/genome analysis, all at the single cell level. This technology is now being introduced across a number of centres in the UK. We would anticipate that the Oxford Centre of Single Cell Biology would lead the way with similar groundbreaking technological advances in the future.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>4975434</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Molecular Haematology Unit seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4BD81861-77D8-4FA9-B1D4-02CAE40BD28F</gtr:id><gtr:impact>A talk regarding the work on single-cell systems biology carried out by the company to date. This sparked a good debate between the presenter and the audience.</gtr:impact><gtr:outcomeId>58c915d7ed93c3.49947622</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Career Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C99B02A2-2180-4A27-A893-26FA115CB3FB</gtr:id><gtr:impact>A career talk to students and post-docs involving working in the USA</gtr:impact><gtr:outcomeId>58c914a5493b36.82757651</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>276500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Training Fellowship (Nicholas Fordham): The Role of EZH2 mutation in paediatric myelodysplasia</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>The Kay Kendall Leukaemia Fund (KKLF)</gtr:fundingOrg><gtr:id>A754EBCF-1FF4-4886-A8E9-BA31B792DE60</gtr:id><gtr:outcomeId>58b6a45c010c71.43193579</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Proximity to Discovery Industry Engagement</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DA167501-B5A8-492D-AB12-B9C978C95CEB</gtr:id><gtr:outcomeId>58b829305e8973.77600420</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>266</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Impact of Leukaemia-Associated Loss of Function of Epigenetic Regulators on Distinct Haematopoietic Stem Cells (Co-applicant with Sten Eirik Jacobsen)</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>The Kay Kendall Leukaemia Fund (KKLF)</gtr:fundingOrg><gtr:id>5EAB8DB6-D2FA-45B7-97F8-13851939C5FA</gtr:id><gtr:outcomeId>58b6a4ef1061b8.03116339</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4975434</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Oxford Single Cell Biology Consortium</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F02B79EC-D81D-4D5B-A911-764BAC4C5CCF</gtr:id><gtr:outcomeId>58b82741654fd5.34619073</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>56000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Discovery Award - Identification and characterisation of cellular targets for genome editing of foetal haematopoietic stem/progenitor cells</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>64C06861-1C3B-4344-868C-80D10963EF23</gtr:id><gtr:outcomeId>58b6a4a9005112.71293115</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>399179</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>John Fell Fund</gtr:department><gtr:description>The Oxford Single Cell Biology Consortium</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>AF2BE893-A0A0-492C-8DE1-93F19C78ACE8</gtr:id><gtr:outcomeId>58b82a7a333456.87336602</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Discovery Award (co-investigator)</gtr:description><gtr:end>2019-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>74FEE677-0C72-4B48-AB86-A85AA0764359</gtr:id><gtr:outcomeId>56dff234548321.19662227</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4975434</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CRI: The Oxford Single Cell Biology Consortium (co-investigator)</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C44D3AED-1AC6-45A3-AADA-7AD5D20279A7</gtr:id><gtr:outcomeId>5460c0b94ba886.11743611</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>248107</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Research Training Fellowship</gtr:department><gtr:description>Wellcome Trust Postdoctoral Research Training Fellowship for Clinician</gtr:description><gtr:end>2019-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>D7BC28C7-9721-4CE3-83A4-E2DA795596DD</gtr:id><gtr:outcomeId>58b55d26307dc5.52476064</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Rosetrees Trust</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:id>D7D6CFFD-A94D-4689-BC05-AB0CFA762535</gtr:id><gtr:outcomeId>5460ba46cec6c1.87391155</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Proximity to discovery Industry Engagement Fund</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>BEB5DA53-258E-4E53-A68A-8494037D5F33</gtr:id><gtr:outcomeId>58b55cd3d668e1.58484486</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2290512A-2427-46B1-86A6-5EC2FE018274</gtr:id><gtr:title>ZIFA: Dimensionality reduction for zero-inflated single-cell gene expression analysis.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d83a935cb3bd7075fd38526fbaa8a13"><gtr:id>7d83a935cb3bd7075fd38526fbaa8a13</gtr:id><gtr:otherNames>Pierson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>56dea48928a322.78999727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ED9D20A-FD54-4643-A64F-AA24E549C861</gtr:id><gtr:title>Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70d30a423e81944842cc60515ff69f8c"><gtr:id>70d30a423e81944842cc60515ff69f8c</gtr:id><gtr:otherNames>Quek L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>58b54408dd9569.51672637</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93F9A783-1CB4-4516-9353-7C76E1185D3B</gtr:id><gtr:title>Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ab8e8f7d43db2d02f8fbaf90a095239"><gtr:id>4ab8e8f7d43db2d02f8fbaf90a095239</gtr:id><gtr:otherNames>Giustacchini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>5a34f662cba531.83770868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9C55984-E3F1-4069-B517-037541E6AAFD</gtr:id><gtr:title>Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c898c712828706075492c628cb10fce"><gtr:id>5c898c712828706075492c628cb10fce</gtr:id><gtr:otherNames>Drissen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>58b54477737268.17646533</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C13CF302-D9F5-4B29-8A00-3B3BA8140189</gtr:id><gtr:title>CalQuo: automated, simultaneous single-cell and population-level quantification of global intracellular Ca2+ responses.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40fa74c28f49eec2ad36195d5e4c36b3"><gtr:id>40fa74c28f49eec2ad36195d5e4c36b3</gtr:id><gtr:otherNames>Fritzsche M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56dea4894d5447.86837069</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF967267-C0F3-4FED-AA4A-4B70A9D31011</gtr:id><gtr:title>Application of single-cell genomics in cancer: promise and challenges.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6951a04aa0c935290484392c1117ca4"><gtr:id>e6951a04aa0c935290484392c1117ca4</gtr:id><gtr:otherNames>Wills QF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56dea488c36d35.16066007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>314AC458-83E6-4D13-B1D5-4C8EB78DCEE0</gtr:id><gtr:title>Assessing similarity to primary tissue and cortical layer identity in induced pluripotent stem cell-derived cortical neurons through single-cell transcriptomics.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32940939798776e174a016529546b916"><gtr:id>32940939798776e174a016529546b916</gtr:id><gtr:otherNames>Handel AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56dea488712962.86501909</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39B64759-39BB-4E9E-B671-C60115B8FDFD</gtr:id><gtr:title>Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e0b20cfc0518dfe2421077726527510"><gtr:id>8e0b20cfc0518dfe2421077726527510</gtr:id><gtr:otherNames>Karamitros D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>5a9ea57fa5bc31.80737550</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AD8DF0D-2C63-4159-A41A-39F03817D672</gtr:id><gtr:title>Expanded GAA repeats impair FXN gene expression and reposition the FXN locus to the nuclear lamina in single cells.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/162c082c41f7e392443803bc1262bde4"><gtr:id>162c082c41f7e392443803bc1262bde4</gtr:id><gtr:otherNames>Silva AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56dea4890044a9.27159359</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>443A5599-3907-4CE0-A1DD-ED7288BBB66D</gtr:id><gtr:title>Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitors.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bc2a33653d404809acfd047a1a3aa3c"><gtr:id>6bc2a33653d404809acfd047a1a3aa3c</gtr:id><gtr:otherNames>Luis TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>58b543d209ec10.04302662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>552DB3AA-1200-4DEA-9AA4-9BDE459D7C58</gtr:id><gtr:title>Statistical approaches and software for clustering islet cell functional heterogeneity.</gtr:title><gtr:parentPublicationTitle>Islets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6951a04aa0c935290484392c1117ca4"><gtr:id>e6951a04aa0c935290484392c1117ca4</gtr:id><gtr:otherNames>Wills QF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1938-2014</gtr:issn><gtr:outcomeId>58c914b7093586.14882743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6F48E86-FBC5-4141-9281-19DBF3828D24</gtr:id><gtr:title>Single-cell RNA sequencing reveals molecular and functional platelet bias of aged haematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/884a8401cd72205f42779a840d6a93a3"><gtr:id>884a8401cd72205f42779a840d6a93a3</gtr:id><gtr:otherNames>Grover A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d518960af25.71638596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95744D5A-EB82-4FDB-AA79-E264DE0C06F9</gtr:id><gtr:title>Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac49b0457a941477ada423553ad6694"><gtr:id>3ac49b0457a941477ada423553ad6694</gtr:id><gtr:otherNames>Booth CAG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>5a9ea3d0928a79.26132155</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA666489-E871-4FA5-AF39-5526C81B4677</gtr:id><gtr:title>Hepcidin is regulated by promoter-associated histone acetylation and HDAC3.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/393f975ed0d279c1e271776d221d70b0"><gtr:id>393f975ed0d279c1e271776d221d70b0</gtr:id><gtr:otherNames>Pasricha SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a35e5e6b96753.06869990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B5A6F60-97A7-49B5-8A52-ECF86153F70A</gtr:id><gtr:title>Separation of cancer cells from white blood cells by pinched flow fractionation.</gtr:title><gtr:parentPublicationTitle>Lab on a chip</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e11ad93ffd41fe60f8ff858ce1476bff"><gtr:id>e11ad93ffd41fe60f8ff858ce1476bff</gtr:id><gtr:otherNames>P?denphant M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-0189</gtr:issn><gtr:outcomeId>5a9ea567030468.99698175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0708EB6-1723-4600-8602-90033D8EFD7F</gtr:id><gtr:title>Hematopoietic Lineage Diversification, Simplified.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c898c712828706075492c628cb10fce"><gtr:id>5c898c712828706075492c628cb10fce</gtr:id><gtr:otherNames>Drissen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>5a9ea590adf360.15358916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>695D4170-2A61-4C36-9FC9-ACF0B5784E3F</gtr:id><gtr:title>Single cell analysis of normal and leukemic hematopoiesis.</gtr:title><gtr:parentPublicationTitle>Molecular aspects of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/768075411d0cbb0e08d1cf0283ee6189"><gtr:id>768075411d0cbb0e08d1cf0283ee6189</gtr:id><gtr:otherNames>Povinelli BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0098-2997</gtr:issn><gtr:outcomeId>5a93d9306080f7.93571492</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81455F3D-F673-42D7-AF7E-00ADB5310046</gtr:id><gtr:title>Hepcidin is regulated by promoter-associated histone acetylation and HDAC3.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/393f975ed0d279c1e271776d221d70b0"><gtr:id>393f975ed0d279c1e271776d221d70b0</gtr:id><gtr:otherNames>Pasricha SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a9ea4f6d22fb5.40289280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA0399EE-92AE-44C1-90B9-26CBE2F4E59F</gtr:id><gtr:title>The nature and nurture of cell heterogeneity: accounting for macrophage gene-environment interactions with single-cell RNA-Seq.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6951a04aa0c935290484392c1117ca4"><gtr:id>e6951a04aa0c935290484392c1117ca4</gtr:id><gtr:otherNames>Wills QF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>58c913e2567c09.82357030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC32F3FA-C856-4D3B-B4A7-B864D5A427AE</gtr:id><gtr:title>pcaReduce: hierarchical clustering of single cell transcriptional profiles.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7089b936d7c291788c6b07fcaf4c97b"><gtr:id>a7089b936d7c291788c6b07fcaf4c97b</gtr:id><gtr:otherNames>?urauskiene J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>58c9146c614899.57707701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C32F3D05-3D5F-4472-9AD8-48156D681E9A</gtr:id><gtr:title>Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a153ccf6d3e6dd4a10a5fe993d848d64"><gtr:id>a153ccf6d3e6dd4a10a5fe993d848d64</gtr:id><gtr:otherNames>Psaila B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58b5449d949b76.96389303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA4088DE-CFE8-4F22-A579-179D194ED674</gtr:id><gtr:title>A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e241df9506cc57c225f4d67f9f5101c"><gtr:id>5e241df9506cc57c225f4d67f9f5101c</gtr:id><gtr:otherNames>Buono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>56dea48899a668.94366922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03EE1234-B7B3-45A1-8DC4-8A1EB45BABE2</gtr:id><gtr:title>Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional program.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9354f6c86b2ab560b899e5bfc3377d1"><gtr:id>d9354f6c86b2ab560b899e5bfc3377d1</gtr:id><gtr:otherNames>Loughran SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>5a6f2d4a6dc902.36785658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BCB1AA6-DB18-4FAC-895D-06E189C5E997</gtr:id><gtr:title>Studying epigenomics in single cells: what is feasible and what can we learn?</gtr:title><gtr:parentPublicationTitle>Epigenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6951a04aa0c935290484392c1117ca4"><gtr:id>e6951a04aa0c935290484392c1117ca4</gtr:id><gtr:otherNames>Wills QF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-192X</gtr:issn><gtr:outcomeId>56d03d3ca47976.64575634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA776308-A4D0-48E9-B8CA-A37CEEC036CC</gtr:id><gtr:title>Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a2a6a343c9659ab8cd4d98f2fe5e8ed"><gtr:id>8a2a6a343c9659ab8cd4d98f2fe5e8ed</gtr:id><gtr:otherNames>McCarthy DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>58c913cab2fd85.50112816</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1009F5F-3792-42D7-B611-4AA863E44063</gtr:id><gtr:title>Order Under Uncertainty: Robust Differential Expression Analysis Using Probabilistic Models for Pseudotime Inference.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8e546acd004a82778811bdffc84f83b"><gtr:id>a8e546acd004a82778811bdffc84f83b</gtr:id><gtr:otherNames>Campbell KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>58c9143c456de3.93059324</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>166BCCA7-CABF-4683-A4E0-7D183BBB57A5</gtr:id><gtr:title>Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fb12a98d4056670ebefede87ebda6ba"><gtr:id>5fb12a98d4056670ebefede87ebda6ba</gtr:id><gtr:otherNames>Mead AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>5a35e41e25da15.14671448</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/M00919X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5191BE6E-A234-4D62-A4F3-B50DBAAE8217</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.5  Resources and infrastructure (detection)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>